Polymorphisms of the drug transporter gene ABCB1 predict side effects of treatment with cabergoline in patients with PRL adenomas.

Author: AthanasouliaA P, BrockhausA C, IsingM, SieversC, StallaG K, UhrM, YassouridisA

Paper Details 
Original Abstract of the Article :
Treatment with dopamine agonists in patients with prolactin (PRL) adenomas and Parkinson's disease is associated with central side effects. Central side effects may depend on a substance's ability to pass the blood-brain barrier, which can be actively controlled by transporter molecules such as the ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1530/EJE-12-0198

データ提供:米国国立医学図書館(NLM)

Genetic Variations and Side Effects of Dopamine Agonists

This study delves into the fascinating world of dopamine agonists, medications that mimic the effects of dopamine, a crucial neurotransmitter involved in movement, mood, and other functions. These medications are used to treat conditions like Parkinson's disease and prolactinomas, tumors in the pituitary gland. The authors focus on how genetic variations in the ABCB1 gene, which encodes a protein called P-glycoprotein, might influence the effectiveness and side effects of these medications.

P-glycoprotein is like a bouncer at a club, controlling which molecules can enter the brain. The study suggests that variations in this gene can affect how well dopamine agonists can cross the blood-brain barrier, impacting their effectiveness and leading to different side effects.

Genetic Variability and Personalized Medicine

These findings highlight the importance of considering individual genetic variations when prescribing medications. It's like recognizing that a patient's genetic makeup might determine whether a drug is the right fit for them, like finding the perfect key for a unique lock. This understanding could lead to more personalized treatments, optimizing drug effectiveness and minimizing side effects.

Understanding the Role of Genetics in Drug Response

This research adds to our understanding of the complex interplay between genetics and drug response. It's like uncovering a new layer in the intricate tapestry of human biology, revealing how our genes influence our reactions to medications. This knowledge can help us develop more effective and safe therapies, tailored to the individual needs of each patient.

Dr. Camel's Conclusion

Exploring the role of genetics in drug response is like embarking on a journey through the vast expanse of human biology. This study on dopamine agonists and the ABCB1 gene reveals how genetic variability can influence medication effectiveness and side effects. This understanding opens doors for personalized medicine, a future where treatments are tailored to the unique needs of each individual, maximizing benefits and minimizing risks.

Date :
  1. Date Completed 2012-11-01
  2. Date Revised 2022-03-21
Further Info :

Pubmed ID

22672924

DOI: Digital Object Identifier

10.1530/EJE-12-0198

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.